DNA microarray for genotyping multidrug-resistant Pseudomonas aeruginosa clinical isolates

被引:16
作者
Weile, Jan [1 ]
Schmid, Rolf D.
Bachmann, Till T.
Susa, Milorad
Knabbe, Cornelius
机构
[1] Robert Bosch Krankenhaus, Dep Lab Med, D-70376 Stuttgart, Germany
[2] Dr Margaret Fisher Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[3] Univ Stuttgart, Inst Techn Biochem, D-70569 Stuttgart, Germany
关键词
Pseudomonas aeruginosa; DNA microarray; antibiotic resistance; nosocomial infections; multidrug resistance;
D O I
10.1016/j.diagmicrobio.2007.06.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The management of infections with multidrug-resistant Pseudomonas aeruginosa needs fast and reliable methods of antibiotic susceptibility testing for a therapy improvement. For this purpose, we developed a DNA microarray for genotyping antibiotic resistance and a few virulence factors. The array covers mutations in the efflux regulators mexR, nfxB, mexT, gyrase gyrA, and parC, as well as plasmid-encoded vim, imp, oxa, aph, aac, and aad genes, and virulence-associated mucA and exoU, exoT, and exoS genes, respectively. The whole procedure can be performed in less than 5 h and consists of DNA isolation, target gene amplification, fluorescence labeling, fragmentation, and array hybridization. Concerning the genotype-phenotype comparison in the test collection, the coverage of relevant resistance determinants for antibiotics used in a calculated therapy of critical ill patients was 87.8%. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:325 / 338
页数:14
相关论文
共 44 条
  • [1] [Anonymous], 2005, PRINCIPLES PRACTISE
  • [2] Antibiotic resistance among gram-negative nosocomial pathogens in the intensive care unit: Results of 6-year body-site monitoring
    Barsic, B
    Beus, I
    Marton, E
    Himbele, J
    Kuzmanovic, N
    Bejuk, D
    Boras, A
    Klinar, I
    [J]. CLINICAL THERAPEUTICS, 1997, 19 (04) : 691 - 700
  • [3] MOLECULAR EPIDEMIOLOGIC ANALYSIS OF PSEUDOMONAS-AERUGINOSA STRAINS CAUSING FAILURE OF ANTIBIOTIC-THERAPY IN CYSTIC-FIBROSIS PATIENTS
    BINGEN, E
    DENAMUR, E
    PICARD, B
    GOULLET, P
    LAMBERTZECHOVSKY, N
    FOUCAUD, P
    NAVARRO, J
    ELION, J
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (05) : 432 - 437
  • [4] Mucoid Pseudomonas aeruginosa in cystic fibrosis: Characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection
    Boucher, JC
    Mudd, HYMH
    Deretic, V
    [J]. INFECTION AND IMMUNITY, 1997, 65 (09) : 3838 - 3846
  • [5] USE OF A PREDICTOR PANEL TO EVALUATE SUSCEPTIBILITY TEST METHODS PROPOSED FOR PIPERACILLIN-TAZOBACTAM
    BRADFORD, PA
    SANDERS, CC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) : 2578 - 2583
  • [6] Aminoglycoside resistance mechanisms in Enterobacteriaceae and Pseudomonas spp from two Danish hospitals: Correlation with type of aminoglycoside used
    BuschSorensen, C
    Sonmezoglu, M
    FrimodtMoller, N
    Hojbjerg, T
    Miller, GH
    Espersen, F
    [J]. APMIS, 1996, 104 (10) : 763 - 768
  • [7] *CDC, 1996, AM J INFECT CONTROL, P380
  • [8] Clinical strain of Pseudomonas aeruginosa carrying a blaTEM-21 gene located on a chromosomal interrupted TnA type transposon
    Dubois, V
    Arpin, C
    Noury, P
    Quentin, C
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) : 3624 - 3626
  • [9] Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
    Feltman, H
    Schulert, G
    Khan, S
    Jain, M
    Peterson, L
    Hauser, AR
    [J]. MICROBIOLOGY-SGM, 2001, 147 : 2659 - 2669
  • [10] Drug therapy - Antimicrobial-drug resistance
    Gold, HS
    Moellering, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19) : 1445 - 1453